Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
The International Journal of Biochemistry & Cell Biology
|
November 7, 2012
Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2
Hao Liu, Peter S Yang, Tina Zhu, et al.
Optics Express
|
May 23, 2009
Demonstration of new technology MEMS and liquid crystal adaptive optics on bright astronomical objects and satellites
David Dayton, John Gonglewski, Sergio Restaino, et al.
Plos One
|
October 23, 2013
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE
Ramzi Khattar, Olga Luft, Nataliya Yavorska, et al.
European Journal of Medicinal Chemistry
|
March 27, 2022
Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease
Yulin Liu, Giuseppe Uras, Itse Onuwaje, et al.
Lancet (London, England)
|
October 11, 2003
Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhood
M James Phillips, Toshifumi Azuma, Sheue-Lim M Meredith, et al.
ACS Chemical Neuroscience
|
November 16, 2022
Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
Xinnan Li, Tiantian Li, Feiyan Zhan, et al.
Leukemia & Lymphoma
|
November 10, 2020
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom
Catherine Garnett, David Foldes, Chris Bailey, et al.
Cell
|
October 23, 2018
Expanding the Optogenetics Toolkit by Topological Inversion of Rhodopsins
Jennifer Brown, Reza Behnam, Luke Coddington, et al.
Leukemia
|
July 31, 2019
The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Steffan T Nawrocki, Yingchun Han, Valeria Visconte, et al.
Immunology
|
July 4, 2014
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts
Peter Urbanellis, Wendy Shyu, Ramzi Khattar, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
The International Journal of Biochemistry & Cell Biology
|
November 7, 2012
Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2
Hao Liu, Peter S Yang, Tina Zhu, et al.
Optics Express
|
May 23, 2009
Demonstration of new technology MEMS and liquid crystal adaptive optics on bright astronomical objects and satellites
David Dayton, John Gonglewski, Sergio Restaino, et al.
Plos One
|
October 23, 2013
Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE
Ramzi Khattar, Olga Luft, Nataliya Yavorska, et al.
European Journal of Medicinal Chemistry
|
March 27, 2022
Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease
Yulin Liu, Giuseppe Uras, Itse Onuwaje, et al.
Lancet (London, England)
|
October 11, 2003
Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhood
M James Phillips, Toshifumi Azuma, Sheue-Lim M Meredith, et al.
ACS Chemical Neuroscience
|
November 16, 2022
Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
Xinnan Li, Tiantian Li, Feiyan Zhan, et al.
Leukemia & Lymphoma
|
November 10, 2020
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom
Catherine Garnett, David Foldes, Chris Bailey, et al.
Cell
|
October 23, 2018
Expanding the Optogenetics Toolkit by Topological Inversion of Rhodopsins
Jennifer Brown, Reza Behnam, Luke Coddington, et al.
Leukemia
|
July 31, 2019
The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Steffan T Nawrocki, Yingchun Han, Valeria Visconte, et al.
Immunology
|
July 4, 2014
The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts
Peter Urbanellis, Wendy Shyu, Ramzi Khattar, et al.
Page
of 15